AR053114A1 - MONOPOTASSIC ACID SALT 2 - {[2 - (- 2-METHYLAMINE-PIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] -AMINO} -3- (PHENYLPIRIDIN-2-IL-AMINO) -PROPIONIC, INHIBITOR FROM IKK-2 QUINASA - Google Patents

MONOPOTASSIC ACID SALT 2 - {[2 - (- 2-METHYLAMINE-PIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] -AMINO} -3- (PHENYLPIRIDIN-2-IL-AMINO) -PROPIONIC, INHIBITOR FROM IKK-2 QUINASA

Info

Publication number
AR053114A1
AR053114A1 ARP060100093A ARP060100093A AR053114A1 AR 053114 A1 AR053114 A1 AR 053114A1 AR P060100093 A ARP060100093 A AR P060100093A AR P060100093 A ARP060100093 A AR P060100093A AR 053114 A1 AR053114 A1 AR 053114A1
Authority
AR
Argentina
Prior art keywords
amino
ikk
phenylpiridin
monopotassic
quinasa
Prior art date
Application number
ARP060100093A
Other languages
Spanish (es)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of AR053114A1 publication Critical patent/AR053114A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Composiciones farmacéuticas que las contienen y usos para tratar enfermedades o procesos patologicos mediados por IKK-2. Reivindicacion 1: Un compuesto de formula (2) o uno de sus solvatos.Pharmaceutical compositions containing them and uses to treat diseases or pathological processes mediated by IKK-2. Claim 1: A compound of formula (2) or one of its solvates.

ARP060100093A 2005-01-12 2006-01-10 MONOPOTASSIC ACID SALT 2 - {[2 - (- 2-METHYLAMINE-PIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] -AMINO} -3- (PHENYLPIRIDIN-2-IL-AMINO) -PROPIONIC, INHIBITOR FROM IKK-2 QUINASA AR053114A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64330005P 2005-01-12 2005-01-12

Publications (1)

Publication Number Publication Date
AR053114A1 true AR053114A1 (en) 2007-04-25

Family

ID=36498772

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100093A AR053114A1 (en) 2005-01-12 2006-01-10 MONOPOTASSIC ACID SALT 2 - {[2 - (- 2-METHYLAMINE-PIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] -AMINO} -3- (PHENYLPIRIDIN-2-IL-AMINO) -PROPIONIC, INHIBITOR FROM IKK-2 QUINASA

Country Status (9)

Country Link
AR (1) AR053114A1 (en)
DO (1) DOP2006000012A (en)
GT (1) GT200600019A (en)
PA (1) PA8659801A1 (en)
PE (1) PE20060954A1 (en)
SV (1) SV2006002374A (en)
TW (1) TW200640905A (en)
UY (1) UY29332A1 (en)
WO (1) WO2006076318A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190026056A (en) 2008-04-21 2019-03-12 오토노미, 인코포레이티드 Auris formulations for treating otic diseases and conditions
US8501166B2 (en) 2010-04-27 2013-08-06 Hutchison Medipharma Limited Pyrimidinyl indole compounds
EP2787998B1 (en) * 2011-12-06 2016-11-09 Sanofi Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
CN109689027A (en) 2016-06-29 2019-04-26 奥德纳米有限公司 Triglycerides aural preparations and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237722A1 (en) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indole or benzimidazole derivatives for the modulation of IKappaB kinase

Also Published As

Publication number Publication date
PA8659801A1 (en) 2006-09-22
SV2006002374A (en) 2006-06-28
PE20060954A1 (en) 2006-10-27
TW200640905A (en) 2006-12-01
UY29332A1 (en) 2006-08-31
WO2006076318A1 (en) 2006-07-20
GT200600019A (en) 2006-09-27
DOP2006000012A (en) 2006-07-15

Similar Documents

Publication Publication Date Title
CU20200046A7 (en) 1,2,4-OXADIAZOLE COMPOUNDS AS INHIBITORS OF CD47 SIGNALING PATHWAYS
CO6180438A2 (en) COMPOUNDS THAT MODULATE ACTIVITY C-FMS AND / OR C-KIT AND USES FOR IT
CR20120268A (en) METHOD FOR REDUCING STRESS BY PLANT TEMPERATURE
AR061500A1 (en) AN ANTIDIABETIC AGENT FOR THE CONTROL OF DIABETIC HYPERGLUCEMIA AND COMPLICATIONS RELATED TO DIABETES
ECSP077163A (en) COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
ECSP099078A (en) AMINO-PIPERIDINE DERIVATIVES AS INHIBITORS OF THE CHOLESTERIL-ESTER TRANSFER PROTEIN (CETP)
UY28747A1 (en) NEW PROCESS FOR SYNTHESIS AND NEW CRYSTAL FORM OF AGOMELATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NI201100166A (en) BENZOFURANIL DERIVATIVES USED AS GLUCOKINASE INHIBITORS
PA8640701A1 (en) USEFUL INDAZOLS FOR TREATMENT OF CARDIOVASCULAR DISEASES
SV2008003045A (en) AMINOTETRAHYDROPIRANS AS DIPERTIDIL INHIBITORS, PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES
UY33246A (en) TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS
ECSP088627A (en) COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
SV2009003286A (en) LIPOXINE A4 ANALOG CRYSTAL POTASSIUM SALT
BRPI0511029A (en) 2 - {[2- (2-Methyl-amino-pyrimidin-4-yl) -1h-indol-5-carbonyl] -amino} -3- (phenyl pyridin-2-yl-amino) -propionic acid as substantially pure a kappa kinase inhibitor
EA201000884A1 (en) DERIVATIVES OF 1,2-DISPOSITED 4-BENZYLAMINOPYRROLIDINE AS A CHOLESTERIL ETHER INHIBITOR INHIBITOR INHIBITORS USED FOR THE TREATMENT OF DISEASES THAT ARE HYPERSHIPERS THYGREADERS.
DK1751093T3 (en) Substituted cyclohexylacetic acid derivatives
AR057909A1 (en) PROCESS TO PREPARE MONTELUKAST AND RELATED COMPOUNDS, USING AN INTERMEDIATE COMPOUND DERIVED FROM A SULFONIC ESTER.
HN2008001490A (en) NEW SYNTHESIS PROCEDURE FOR THE STRONTIUM RANELATE AND ITS HYDRATS
AR053114A1 (en) MONOPOTASSIC ACID SALT 2 - {[2 - (- 2-METHYLAMINE-PIRIMIDIN-4-IL) -1H-INDOL-5-CARBONIL] -AMINO} -3- (PHENYLPIRIDIN-2-IL-AMINO) -PROPIONIC, INHIBITOR FROM IKK-2 QUINASA
CY1109569T1 (en) Substituted cyclohexane-1,4-diamine derivatives
AR064658A1 (en) PROCESS TO PREPARE DULOXETINE AND ITS RELATED COMPOUNDS, AS WELL AS ALSO USEFUL INTERMEDIARIES IN THE SAME
CR10792A (en) COMBINATIONS OF HERBICIDES WITH SPECIAL SULFONILURES
BR112014016412A2 (en) method and system for producing produced water
EA200600878A1 (en) PHENOXYACIC ACID DERIVATIVES APPLICABLE AS A DOUBLE AGONISTS ACTIVATED BY A PEROXYSOMIC PROTECTOR (PPAR)
GT200700105A (en) XA FACTOR INHIBITOR

Legal Events

Date Code Title Description
FA Abandonment or withdrawal